Discount Code (0% Off) has been applied.
 
0
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item
Ketorolac Tromethamine Injection 30 mg/mL, Single Dose Vial 2 mL, Each
Ketorolac Tromethamine Injection 30 mg/mL, Single Dose Vial 2 mL, Each
Manufacturer: Hospira

Ketorolac Tromethamine Injection, USP is a potent nonsteroidal anti-inflammatory drug (NSAID) designed for short-term (up to 5 days) management of moderately severe acute pain that requires opioid-level analgesia. It is available for both intravenous (IV) and intramuscular (IM) administration.

 

Key Benefits:

  • Effective Pain Relief: Provides opioid-level analgesia for managing acute pain, particularly in post-operative settings.
  • Short-Term Use: Intended for use up to 5 days in adults, ensuring pain relief while minimizing long-term risks associated with NSAID use.
  • Multi-Route Administration: Available for both IV and IM administration, offering flexibility based on patient needs.

 

Dosage and Administration:

  • Adults <65 Years of Age: Recommended dose is 30 mg IV or IM every 6 hours, with a maximum daily dose of 120 mg.
  • Adults ≥65 Years, Renally Impaired, or Less Than 50 kg: 15 mg every 6 hours, with a maximum daily dose of 60 mg. The combined duration of use of IV/IM and oral ketorolac tromethamine should not exceed 5 days. Transition to oral dosing should occur only after IV or IM administration if necessary.

 

Why Choose Ketorolac Tromethamine Injection?

  • Potent NSAID Action: Effective in providing strong pain relief without the sedative effects associated with opioids.
  • Short-Term Efficacy: Ideal for situations where powerful, temporary pain control is required.
  • Clinically Tested: Widely used in post-surgical settings for its strong analgesic properties.

 

Warnings:

  • Gastrointestinal Risks: Can cause serious gastrointestinal issues, such as bleeding and ulcers, which may occur without warning.
  • Cardiovascular and Renal Risks: Increased risk of cardiovascular events such as myocardial infarction and stroke. Not recommended for patients with advanced renal impairment.
  • Bleeding Risk: Contraindicated in patients at high risk of bleeding, those undergoing major surgery, or in labor and delivery.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

 

Manufacturer: Hospira

Ketorolac Tromethamine Injection 30 mg/mL, Single Dose Vial 2 mL, Each

$8.38 per Each
Item Code: 005419
Mfg Part #: 00409-3796-25
EachTray
This product is only available to licensed healthcare professionals.
Select your shipping method. This is helpful to expedite a portion of your order.
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
  Usually ships within 24 hours.
Overview

Ketorolac Tromethamine Injection, USP is a potent nonsteroidal anti-inflammatory drug (NSAID) designed for short-term (up to 5 days) management of moderately severe acute pain that requires opioid-level analgesia. It is available for both intravenous (IV) and intramuscular (IM) administration.

 

Key Benefits:

  • Effective Pain Relief: Provides opioid-level analgesia for managing acute pain, particularly in post-operative settings.
  • Short-Term Use: Intended for use up to 5 days in adults, ensuring pain relief while minimizing long-term risks associated with NSAID use.
  • Multi-Route Administration: Available for both IV and IM administration, offering flexibility based on patient needs.

 

Dosage and Administration:

  • Adults <65 Years of Age: Recommended dose is 30 mg IV or IM every 6 hours, with a maximum daily dose of 120 mg.
  • Adults ≥65 Years, Renally Impaired, or Less Than 50 kg: 15 mg every 6 hours, with a maximum daily dose of 60 mg. The combined duration of use of IV/IM and oral ketorolac tromethamine should not exceed 5 days. Transition to oral dosing should occur only after IV or IM administration if necessary.

 

Why Choose Ketorolac Tromethamine Injection?

  • Potent NSAID Action: Effective in providing strong pain relief without the sedative effects associated with opioids.
  • Short-Term Efficacy: Ideal for situations where powerful, temporary pain control is required.
  • Clinically Tested: Widely used in post-surgical settings for its strong analgesic properties.

 

Warnings:

  • Gastrointestinal Risks: Can cause serious gastrointestinal issues, such as bleeding and ulcers, which may occur without warning.
  • Cardiovascular and Renal Risks: Increased risk of cardiovascular events such as myocardial infarction and stroke. Not recommended for patients with advanced renal impairment.
  • Bleeding Risk: Contraindicated in patients at high risk of bleeding, those undergoing major surgery, or in labor and delivery.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

 

Specifications

Ketorolac Tromethamine Injection, USP is a potent nonsteroidal anti-inflammatory drug (NSAID) designed for short-term (up to 5 days) management of moderately severe acute pain that requires opioid-level analgesia. It is available for both intravenous (IV) and intramuscular (IM) administration.

 

Key Benefits:

  • Effective Pain Relief: Provides opioid-level analgesia for managing acute pain, particularly in post-operative settings.
  • Short-Term Use: Intended for use up to 5 days in adults, ensuring pain relief while minimizing long-term risks associated with NSAID use.
  • Multi-Route Administration: Available for both IV and IM administration, offering flexibility based on patient needs.

 

Dosage and Administration:

  • Adults <65 Years of Age: Recommended dose is 30 mg IV or IM every 6 hours, with a maximum daily dose of 120 mg.
  • Adults ≥65 Years, Renally Impaired, or Less Than 50 kg: 15 mg every 6 hours, with a maximum daily dose of 60 mg. The combined duration of use of IV/IM and oral ketorolac tromethamine should not exceed 5 days. Transition to oral dosing should occur only after IV or IM administration if necessary.

 

Why Choose Ketorolac Tromethamine Injection?

  • Potent NSAID Action: Effective in providing strong pain relief without the sedative effects associated with opioids.
  • Short-Term Efficacy: Ideal for situations where powerful, temporary pain control is required.
  • Clinically Tested: Widely used in post-surgical settings for its strong analgesic properties.

 

Warnings:

  • Gastrointestinal Risks: Can cause serious gastrointestinal issues, such as bleeding and ulcers, which may occur without warning.
  • Cardiovascular and Renal Risks: Increased risk of cardiovascular events such as myocardial infarction and stroke. Not recommended for patients with advanced renal impairment.
  • Bleeding Risk: Contraindicated in patients at high risk of bleeding, those undergoing major surgery, or in labor and delivery.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

 
Products specifications
Manufacturer: Hospira

Ketorolac Tromethamine Injection 30 mg/mL, Single Dose Vial 2 mL, 25/Tray

$188.55 ($7.54 / Each) You save 10%
Item Code: 009934
Mfg Part #: 00409-3796-25
EachTray
This product is only available to licensed healthcare professionals.
Select your shipping method. This is helpful to expedite a portion of your order.
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
  Usually ships within 24 hours.
Overview

Ketorolac Tromethamine Injection, USP is a potent nonsteroidal anti-inflammatory drug (NSAID) designed for short-term (up to 5 days) management of moderately severe acute pain that requires opioid-level analgesia. It is available for both intravenous (IV) and intramuscular (IM) administration.

 

Key Benefits:

  • Effective Pain Relief: Provides opioid-level analgesia for managing acute pain, particularly in post-operative settings.
  • Short-Term Use: Intended for use up to 5 days in adults, ensuring pain relief while minimizing long-term risks associated with NSAID use.
  • Multi-Route Administration: Available for both IV and IM administration, offering flexibility based on patient needs.

 

Dosage and Administration:

  • Adults <65 Years of Age: Recommended dose is 30 mg IV or IM every 6 hours, with a maximum daily dose of 120 mg.
  • Adults ≥65 Years, Renally Impaired, or Less Than 50 kg: 15 mg every 6 hours, with a maximum daily dose of 60 mg. The combined duration of use of IV/IM and oral ketorolac tromethamine should not exceed 5 days. Transition to oral dosing should occur only after IV or IM administration if necessary.

 

Why Choose Ketorolac Tromethamine Injection?

  • Potent NSAID Action: Effective in providing strong pain relief without the sedative effects associated with opioids.
  • Short-Term Efficacy: Ideal for situations where powerful, temporary pain control is required.
  • Clinically Tested: Widely used in post-surgical settings for its strong analgesic properties.

 

Warnings:

  • Gastrointestinal Risks: Can cause serious gastrointestinal issues, such as bleeding and ulcers, which may occur without warning.
  • Cardiovascular and Renal Risks: Increased risk of cardiovascular events such as myocardial infarction and stroke. Not recommended for patients with advanced renal impairment.
  • Bleeding Risk: Contraindicated in patients at high risk of bleeding, those undergoing major surgery, or in labor and delivery.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

 

Specifications

Ketorolac Tromethamine Injection, USP is a potent nonsteroidal anti-inflammatory drug (NSAID) designed for short-term (up to 5 days) management of moderately severe acute pain that requires opioid-level analgesia. It is available for both intravenous (IV) and intramuscular (IM) administration.

 

Key Benefits:

  • Effective Pain Relief: Provides opioid-level analgesia for managing acute pain, particularly in post-operative settings.
  • Short-Term Use: Intended for use up to 5 days in adults, ensuring pain relief while minimizing long-term risks associated with NSAID use.
  • Multi-Route Administration: Available for both IV and IM administration, offering flexibility based on patient needs.

 

Dosage and Administration:

  • Adults <65 Years of Age: Recommended dose is 30 mg IV or IM every 6 hours, with a maximum daily dose of 120 mg.
  • Adults ≥65 Years, Renally Impaired, or Less Than 50 kg: 15 mg every 6 hours, with a maximum daily dose of 60 mg. The combined duration of use of IV/IM and oral ketorolac tromethamine should not exceed 5 days. Transition to oral dosing should occur only after IV or IM administration if necessary.

 

Why Choose Ketorolac Tromethamine Injection?

  • Potent NSAID Action: Effective in providing strong pain relief without the sedative effects associated with opioids.
  • Short-Term Efficacy: Ideal for situations where powerful, temporary pain control is required.
  • Clinically Tested: Widely used in post-surgical settings for its strong analgesic properties.

 

Warnings:

  • Gastrointestinal Risks: Can cause serious gastrointestinal issues, such as bleeding and ulcers, which may occur without warning.
  • Cardiovascular and Renal Risks: Increased risk of cardiovascular events such as myocardial infarction and stroke. Not recommended for patients with advanced renal impairment.
  • Bleeding Risk: Contraindicated in patients at high risk of bleeding, those undergoing major surgery, or in labor and delivery.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

 
Products specifications

Contact Us

McGuff Company is LegitScript Certified

Verify Approval for www.mcguff.com

Copyright © 2025 McGuff Company, Inc. All rights reserved.

For information on the duties and responsibilities of this web site, please read our privacy policy and our warning and disclaimer. Use of this website signifies your agreement to the Privacy Policy and Warning Disclaimer.